|
2026 Conference Publication Machine Learning-Generated Longitudinal Synthetic International Data in Multiple SclerosisIqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, Slee, Mark, Mccombe, Pamela, Taylor, Bruce, Foong, Yi Chao, Macdonell, Richard, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Field, Deborah, Massey, Jennifer, Malpas, Charles, Roos, Izanne and Kalincik, Prof Tomas (2026). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Causal effects of multiple sclerosis therapies in left-truncated registry dataHaile, Dagmawi, Diouf, Ibrahima, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Macdonell, Richard, Barnett, Michael, Shaw, Cameron, Massey, Jennifer, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Hodgkinson, Suzanne, Garber, Justin, John, Nevin, Lechner-Scott, Jeannette, Slee, Mark, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., McCombe, Pamela, Foong, Yi Chao, Taylor, Bruce, Ferrando, Beatriz Romero, Stuart, Elizabeth, Sharmin, Sifat, Roos, Izanne and Kalincik, Tomas (2026). Causal effects of multiple sclerosis therapies in left-truncated registry data. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 yearsMuller, Jannis, Buzzard, Kathrine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan G., Fabris-Pedrini, Marzena, Carroll, William M., Macdonell, Richard, Slee, Mark, Kuhle, Jens, Amato, Maria Pia, Trojano, Maria, Kalincik, Tomas and Roos, Izanne (2026). Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Cessation of anti-trafficking therapies after the age of 50 yearsMuller, Jannis, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan, Fabis-Pedrini, Marzena, Macdonell, Richard, Slee, Mark, Garber, Justin, Kuhle, Jens, Kappos, Ludwig, Amato, Maria Pia, Trojan, Maria, Kalincik, Tomas and Roos, Izanne (2026). Cessation of anti-trafficking therapies after the age of 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin, Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Girard, Marc ... Van Der Walt, Anneke (2026). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Bayesian networks to generate representative longitudinal data in multiple sclerosisQiang, Zhe, Iqbal, Hassam, Sharmina, Sifat, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeanette, John, Nevin, Buzzard, Katherine, Skibina, Olga, Barnett, Michael, Mccombe, Pamela, Hodgkinson, Suzanne, Macdonell, Richard, Slee, Mark, Hardy, Todd, Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Taylor, Bruce, Foong, Yi Chao, Garber, Justin, Field, Deborah, Malpas, Charles, Roos, Izanne and Kalincik, Tomas (2026). Bayesian networks to generate representative longitudinal data in multiple sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Long-term prognostic value of confirmed disability improvements in multiple sclerosisLizak, Nathaniel, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Barnett, Michael, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., John, Nevin, Macdonell, Richard, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Taylor, Bruce, Garber, Justin, Ferrando, Beatriz Romero, Mason, Deborah, Hardy, Todd, Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Massey, Jennifer, Shaw, Cameron, Field, Deborah, Shuey, Neil, Roos, Izanne and Kalincik, Tomas (2026). Long-term prognostic value of confirmed disability improvements in multiple sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort studyRoos, Izanne, Sharmin, Sifat, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Lechner-Scott, Jeannette, John, Nevin, Macdonell, Richard, Mccombe, Pamela, Hodgkinson, Suzanne, Kermode, Allan, Vukusic, Sandra, Magyari, Melinda, Laplaud, David and Kalincik, Tomas (2026). Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort study. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset TimingSajedi, Seyed Aidin, Zhu, Chao, Abdollahi, Fahimeh, Saberi, Fatemeh, Horakova, Dana, Ozakbas, Serkan, Zakaria, Magd, Shaygannejad, Vahid, Etemadifar, Masoud, Khoury, Samia J., Weinstock-Guttman, Bianca, Patti, Francesco, Boz, Cavit, Eichau, Sara, Tomassini, Valentina, Terzi, Murat, Duquette, Pierre, Kermode, Allan G., Karelis, Guntis, Amato, Maria Pia, Libertinova, Jana, Grand'Maison, Francois, Shalaby, Nevin, Kalincik, Tomas, Buzzard, Katherine, Habek, Mario, Blanco, Yolanda, Grammond, Pierre, Lechner-Scott, Jeannette ... Butzkueven, Helmut (2026). Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalationDaruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertínová, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, Walt, Anneke van der, Butzkueven, Helmut, Meca-Lallana, Jose E, Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, McCombe, Pamela, Ayuso, Guillermo Izquierdo, Eichau, Sara ... on behalf of the MSBase study group (2025). Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation. Annual Meeting of the Association-of-British-Neurologists (ABN), Liverpool, England, 6-9 May 2025. London, United Kingdom: BMJ Group. doi: 10.1136/jnnp-2025-abn.247 |
|
2025 Conference Publication MS outcomes in breast cancer survivors and the influence of chemotherapyNesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Lechner-Scott, Jeannette, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Pedrini, Marzena, Carroll, William, Barnett, Michael, Taylor, Bruce, Hodgkinson, Suzanne, Barnett, Michael, Mccombe, Pamela, Reddel, Stephen, Vucic, Steve, Ramanathan, Sudarshini, Macdonell, Richard ... Jokubaitis, Vilija (2025). MS outcomes in breast cancer survivors and the influence of chemotherapy. ANZAN Annual Scientific Meeting 2025, Brisbane, QLD, Australia, 10-13 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.6 |
|
2025 Conference Publication Targeted nanopore long-read sequencing improves diagnosis of genetic myopathiesYeow, Dennis, Stevanovski, Igor, Reis, Andre LM, Rudaks, Laura I, Chintalaphani, Sanjog R, Grosz, Bianca, Liang, Christina, Morris, Katrina A, Reddel, Stephen, McCombe, Pamela A, Zhu, Danqing, Stoll, Marion, Davis, Ryan L, Manser, David, Tchan, Michel, Worgan, Lisa, Hannaford, Andrew, Sue, Carolyn M, Shandiz, Ehsan, Ahmad, Kate E, Ghaoui, Roula, Barnes, Stephanie L, Sturm, Jonathan, Willard, Anna, Hawke, Simon, Ng, Karl, Cheong, Pak Leng, Kennerson, Marina L, Kumar, Kishore R and Deveson, Ira W (2025). Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies. ANZAN Annual Scientific Meeting 2025, Brisbane, QLD, Australia, 10-13 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.5 |
|
2025 Conference Publication Preserving neurological function in people at high and low risk of aggressive multiple sclerosisRoos, Izanne, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Walt, Anneke van der, Butzkueven, Helmut, Barnett, Michael, Macdonell, Richard, John, Nevin, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Garber, Justin, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Taylor, Bruce, Vukusic, Sandra and Kalincik, Tomas (2025). Preserving neurological function in people at high and low risk of aggressive multiple sclerosis. ANZAN Annual Scientific Meeting 2025, Sydney, NSW Australia, 23-26 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.153 |
|
2025 Conference Publication Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple SclerosisGomez Figueroa, Enrique, Orozco Puga, Patricia, Corona Vazquez, Cynthia, Moreno Bernardino, Carlos Javier, De la Mora Landin, Graciela, Jimenez-Ruiz, Amado, Garcia Estrada, Christian Alan, Zertuche-Ortuno, Lizeth, Saldivar Davila, Sergio, Rivas, Roberto Rodriguez, Bazan, Anna Lisette, Rivera, Jose Flores, Kalincik, Tomas, Buzzard, Katherine, Khoury, Samia, Duquette, Pierre, Foschi, Matteo, Surcinelli, Andrea, Weinstock-Guttman, Bianca, Gouider, Riadh, Mrabet, Saloua, Lechner-Scott, Jeannette, Butzkueven, Helmut, Alroughani, Raed, Roos, Izanne, Patti, Francesco, Spitaleri, Daniele, McCombe, Pamela, Sanchez Menoyo, Jose Luis ... Ruiz-Sandoval, Jose Luis (2025). Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Bayesian network to generate representative longitudinal data in multiple sclerosisQiang, Zhe, Iqbal, Hassam, Sharmin, Sifat, Ozakbas, Serkan, Zakaria, Magd Fouad, Etemadifar, Masoud, Alroughani, Raed, Boz, Cavit, Karabudak, Rana, Shaygannejad, Vahid, Habek, Mario, Terzi, Murat, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Kermode, Allan, Pedrini, Marzena, Carroll, William, Horakova, Dana, Havrdova, Eva, Soysal, Aysun, Altintas, Ayse, Turkoglu, Recai, Gouider, Riadh, Mrabet, Saloua, Ayuso, Guillermo Izquierdo ... Kalincik, Tomas (2025). Bayesian network to generate representative longitudinal data in multiple sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort studyRoos, Izanne, Sharmin, Sifat, Horakova, Dana, Ozakbas, Serkan, Libertinova, Jana, Boz, Cavit, Alroughani, Raed, Barnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Rous, Zuzana, Mares, Miroslav, Buzzard, Katherine, Peterka, Marek, Scott, Jeannette Lechner, Foschi, Matteo, Surcinelli, Andrea, Hradilek, Pavel, Prevost, Julie, Brown, William, Eichau, Sara, Blanco, Yolanda, Terzi, Murat, Meca-Lallana, Jose E., Laureys, Guy, Grammond, Pierre, John, Nevin A., Soysal, Aysun, Ampapa, Radek ... Kalincik, Tomas (2025). Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort study. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?Hradilek, Pavel, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana, Peterka, Marek, Stourac, Pavel, Mares, Jan, Alroughani, Raed, Ozakbas, Serkan, Karabudak, Rana, Boz, Cavit, Yammout, Bassem, Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Scott, Jeannette Lechner, McGuigan, Christopher, Prat, Alexandre ... Fistravec, Gregor (2025). Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 UpdateSpelman, Tim, van der Walt, Anneke, Ozakbas, Serkan, Horakova, Dana, Alroughani, Raed, Kalincik, Tomas, Boz, Cavit, Buzzard, Katherine, Kermode, Allan, Gerlach, O., Foschi, Matteo, Jakob, Gregor Brecl, Grigoriadis, Nikolaos, Prevost, Julie, Duquette, Pierre, Lapointe, Emmanuelle, D'Amico, Emanuele, Ampapa, Radek, Gross-Paju, Katrin, Grammond, Pierre, Cardenas-Robledo, Simon, Houskova, Jana, Khoury, Samia, Maimone, Davide, Sanchez, Jose Luis, McCombe, Pamela, Slee, Mark, Taylor, Bruce, Blanco, Yolanda ... Butzkueven, Helmut (2025). Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalationDaruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertinova, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, van der Walt, Anneke, Butzkueven, Helmut, Meca-Lallana, Jose E., Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, Mccombe, Pamela, Izquierdo Ayuso, Guillermo, Eichau, Sara ... Brown, William (2025). Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2025 Conference Publication Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple SclerosisStastna, Dominika, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Kovarova, Ivana, Barnett, Michael, Kalincik, Tomas, Buzzard, Katherine, van der Walt, Anneke, Macdonell, Richard, Scott, Jeannette Lechner, John, Nevin A., Mccombe, Pamela, Hodgkinson, Suzanne, Taylor, Bruce, Slee, Mark, Garber, Justin, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Hradilek, Pavel, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana ... Fistravec, Gregor (2025). Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD. |
